Literature DB >> 6158966

Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma.

H K Silver, K A Karim, F A Salinas.   

Abstract

Reported elevations of total serum sialic acid may be a result of shed tumour-related membrane sialyglycoprotein and/or concurrent elevation of non-specific, acute-phase reactant sialoglycoprotein. To clarify further the specificity and sensitivity of serum sialic acid monitoring, analyses of sialic acid by the thiobarbituric acid method and acute-phase reactants by radial immunodiffusion were made using the same malignant melanoma patients' sera. Preliminary studies of IgG, IgA, IgM, ceruloplasmin and C-reactive protein suggested that these would not be valuable monitors of tumour burden. Single serum samples from 59 melanoma patients and age- and sex-matched controls were further examined for sialic acid, alpha 1-acid glycoprotein, alpha 1-antitrypsin, haptoglobin, and alpha 2-macroglobulin. Patients were grouped according to tumour burden. In pairwise statistical tests, differences between groups tended to be greater for sialic acid than for acute-phase reactants. On discriminant analysis , sialic acid was clearly the most significant single discriminator between groups, with an F statistic of P < 0.00005. Although alpha 1-acid glycoprotein was quite strongly correlated with sialic acid, it was not such a good discriminator and did not add significantly to the predictive power of sialic acid alone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6158966      PMCID: PMC2010328          DOI: 10.1038/bjc.1980.136

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Increased sialic acid density in surface glycoprotein of transformed and malignant cells--a general phenomenon?

Authors:  W P van Beek; L A Smets; P Emmelot
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

2.  Sialic cid in human cancer.

Authors:  E W Mabry; R Carubelli
Journal:  Experientia       Date:  1972-02-15

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Serum haptoglobin in patients with ovarian malignancies.

Authors:  W K Mueller; R Handschumacher; M E Wade
Journal:  Obstet Gynecol       Date:  1971-09       Impact factor: 7.661

5.  Alpha Fetoprotein: An index of progression or regression of hepatoma, and a target for immunotherapy.

Authors:  L C Parks; A N Baer; M Pollack; G M Williams
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

6.  Radioimmunoassay for human alpha 1 -fetoprotein.

Authors:  H K Silver; P Gold; S Feder; S O Freedman; J Shuster
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

7.  Detection of tumor-associated antigen in human melanoma cell line supernatants.

Authors:  E A Grimm; H K Silver; J A Roth; D O Chee; R K Gupta; D L Morton
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

8.  Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis.

Authors:  P Dhar; T Moore; N Zamcheck; H Z Kupchik
Journal:  JAMA       Date:  1972-07-03       Impact factor: 56.272

9.  Biochemical markers in human breast cancer.

Authors:  R C Coombes; T J Powles; J C Gazet; H T Ford; J P Sloane; D J Laurence; A M Neville
Journal:  Lancet       Date:  1977-01-15       Impact factor: 79.321

10.  Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes.

Authors:  A M Ward; E H Cooper; R Turner; J A Anderson; A M Neville
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

View more
  3 in total

1.  Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers.

Authors:  G A Turner; A W Skillen; P Buamah; D Guthrie; J Welsh; J Harrison; A Kowalski
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

2.  Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data.

Authors:  Lazaro Hiram Betancourt; Krzysztof Pawłowski; Jonatan Eriksson; A Marcell Szasz; Shamik Mitra; Indira Pla; Charlotte Welinder; Henrik Ekedahl; Per Broberg; Roger Appelqvist; Maria Yakovleva; Yutaka Sugihara; Kenichi Miharada; Christian Ingvar; Lotta Lundgren; Bo Baldetorp; Håkan Olsson; Melinda Rezeli; Elisabet Wieslander; Peter Horvatovich; Johan Malm; Göran Jönsson; György Marko-Varga
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

3.  Quantitative evaluation and correlation of serum glycoconjugates: Protein bound hexoses, sialic acid and fucose in leukoplakia, oral sub mucous fibrosis and oral cancer.

Authors:  K Subhash Chandra Bose; Prerna Vyas Gokhale; Sunil Dwivedi; Manika Singh
Journal:  J Nat Sci Biol Med       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.